Shitong Lin

1.2k total citations · 1 hit paper
35 papers, 466 citations indexed

About

Shitong Lin is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Shitong Lin has authored 35 papers receiving a total of 466 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 11 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Shitong Lin's work include Cancer-related molecular mechanisms research (9 papers), Single-cell and spatial transcriptomics (5 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Shitong Lin is often cited by papers focused on Cancer-related molecular mechanisms research (9 papers), Single-cell and spatial transcriptomics (5 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Shitong Lin collaborates with scholars based in China, Hong Kong and India. Shitong Lin's co-authors include Canhui Cao, Wenhua Zhi, Ping Wu, Yifan Meng, Peng Wu, Peipei Gao, Wencheng Ding, Ting Peng, Juncheng Wei and Binghan Liu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Human Molecular Genetics and Annals of Oncology.

In The Last Decade

Shitong Lin

33 papers receiving 459 citations

Hit Papers

Spatial multi-omics: deciphering technological landscape ... 2024 2026 2025 2024 10 20 30 40 50

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shitong Lin China 15 205 143 120 80 76 35 466
Roubini Zakopoulou Greece 10 358 1.7× 144 1.0× 132 1.1× 24 0.3× 49 0.6× 29 533
Liting You China 9 182 0.9× 152 1.1× 65 0.5× 42 0.5× 73 1.0× 25 412
D-A Silasi United States 6 147 0.7× 168 1.2× 87 0.7× 26 0.3× 140 1.8× 12 428
Omar López-Ocejo Cuba 7 151 0.7× 123 0.9× 109 0.9× 120 1.5× 92 1.2× 8 367
Jéssica Rodrigues Plaça Brazil 14 323 1.6× 50 0.3× 206 1.7× 53 0.7× 75 1.0× 28 495
Yoshiteru Murofushi Japan 10 176 0.9× 87 0.6× 49 0.4× 26 0.3× 78 1.0× 14 376
Hongxia Li China 14 337 1.6× 126 0.9× 247 2.1× 61 0.8× 62 0.8× 39 575
D Bonifacio Italy 10 228 1.1× 98 0.7× 144 1.2× 160 2.0× 38 0.5× 12 405
Ha Zhu China 10 305 1.5× 165 1.2× 214 1.8× 35 0.4× 304 4.0× 12 624
Andrzej Kram Poland 13 230 1.1× 149 1.0× 105 0.9× 32 0.4× 27 0.4× 50 500

Countries citing papers authored by Shitong Lin

Since Specialization
Citations

This map shows the geographic impact of Shitong Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shitong Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shitong Lin more than expected).

Fields of papers citing papers by Shitong Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shitong Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shitong Lin. The network helps show where Shitong Lin may publish in the future.

Co-authorship network of co-authors of Shitong Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Shitong Lin. A scholar is included among the top collaborators of Shitong Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shitong Lin. Shitong Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cao, Canhui, Ting Peng, Xiaojie Liu, et al.. (2025). Blocking CXCR4+ CD4+ T cells reprograms Treg-mediated immunosuppression via modulating the Rho-GTPase/NF-κB signaling axis. Genome Medicine. 17(1). 85–85. 1 indexed citations
2.
Luo, Lixia, et al.. (2024). Molecular mechanism of Rolupram reducing neuroinflammation in noise induced tinnitus mice through TLR4/NF kB/NLRP3 protein/caspase-1/IL-1 β signaling pathway. International Journal of Biological Macromolecules. 278(Pt 4). 134987–134987. 6 indexed citations
3.
Cao, Canhui, Wei Ye, Ting Peng, et al.. (2024). CXCR4 orchestrates the TOX-programmed exhausted phenotype of CD8+ T cells via JAK2/STAT3 pathway. Cell Genomics. 4(10). 100659–100659. 14 indexed citations
5.
Xu, Jingjing, Xinrui Shi, Shitong Lin, et al.. (2024). Chimeric RNA landscape in the placenta: A transcriptomic analysis revealing novel diagnostic biomarkers forpreeclampsia. Genes & Diseases. 12(1). 101242–101242.
6.
Lin, Shitong, et al.. (2024). Whether surgical procedure can improve the prognosis of endometrial cancer arising in adenomyosis (EC-AIA)? A systematic review and meta-analysis. International Journal of Surgery. 110(5). 3072–3080. 2 indexed citations
7.
Ye, Wei, Shitong Lin, Wenhua Zhi, et al.. (2023). Genomic analysis of cervical carcinoma identifies Alpelisib as a therapeutic option for PIK3CA‐mutant cervical carcinoma via the PI3K/AKT pathway. Journal of Medical Virology. 95(3). e28656–e28656. 14 indexed citations
8.
Lin, Shitong, Binghan Liu, Lingling Zheng, et al.. (2023). A novel cuproptosis-related gene signature for overall survival prediction in uterine corpus endometrial carcinoma (UCEC). Heliyon. 9(4). e14613–e14613. 4 indexed citations
9.
Ye, Wei, Xiaoyu Liu, Shitong Lin, et al.. (2023). Single‐cell transcriptome analysis of the mouse and primate ovaries reveals oocyte‐specific expression patterns of risk genes in ovarian aging. SHILAP Revista de lepidopterología. 4(2). e209–e209. 5 indexed citations
10.
Lin, Shitong, Canhui Cao, Binghan Liu, et al.. (2023). Single-nucleus RNA sequencing reveals heterogenous microenvironments and specific drug response between cervical squamous cell carcinoma and adenocarcinoma. EBioMedicine. 97. 104846–104846. 22 indexed citations
11.
Wang, Lingfang, Jian Zhang, Yasen Maimaitiyiming, et al.. (2022). Distinct Roles of m5C RNA Methyltransferase NSUN2 in Major Gynecologic Cancers. Frontiers in Oncology. 12. 786266–786266. 43 indexed citations
12.
Peng, Ting, Binghan Liu, Shitong Lin, et al.. (2022). APOBEC3G expression correlates with unfavorable prognosis and immune infiltration in kidney renal clear cell carcinoma. Heliyon. 8(12). e12191–e12191. 4 indexed citations
13.
Peng, Ting, Shitong Lin, Yifan Meng, et al.. (2022). LOXL2 small molecule inhibitor restrains malignant transformation of cervical cancer cells by repressing LOXL2-induced epithelial-mesenchymal transition (EMT). Cell Cycle. 21(17). 1827–1841. 14 indexed citations
14.
Zhi, Wenhua, Wei Ye, Yifan Meng, et al.. (2022). HPV‐ CCDC106 integration promotes cervical cancer progression by facilitating the high expression of CCDC106 after HPV E6 splicing. Journal of Medical Virology. 95(1). 13 indexed citations
15.
Gao, Peipei, Ting Peng, Shitong Lin, et al.. (2021). Key Role of MCUR1 in Malignant Progression of Breast Cancer. OncoTargets and Therapy. Volume 14. 4163–4175. 5 indexed citations
16.
Gao, Peipei, Ting Peng, Canhui Cao, et al.. (2021). Association of CLDN6 and CLDN10 With Immune Microenvironment in Ovarian Cancer: A Study of the Claudin Family. Frontiers in Genetics. 12. 595436–595436. 17 indexed citations
17.
Meng, Yifan, Yan Liu, Shitong Lin, et al.. (2020). The effects of uterine manipulators in minimally invasive hysterectomy for endometrial cancer: A systematic review and meta-analysis. European Journal of Surgical Oncology. 46(7). 1225–1232. 18 indexed citations
19.
Lin, Shitong, Yifan Meng, Canhui Cao, et al.. (2020). Comprehensive analysis of LDHAP5 pseudogene expression and potential pathogenesis in ovarian serous cystadenocarcinoma. Cancer Cell International. 20(1). 229–229. 6 indexed citations
20.
Gao, Peipei, Canhui Cao, Yifan Meng, et al.. (2019). Immune checkpoint inhibitors in the treatment of virus-associated cancers. Journal of Hematology & Oncology. 12(1). 58–58. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026